Sensitivity as outcome measure of androgen replacement: the AMS scale

BACKGROUND: The capacity of the AMS scale as clinical utility and as outcome measure still needs validation. METHODS: An open post-marketing study was performed by office-based physicians in Germany in 2004. We analysed data of 1670 androgen-deficient males who were treated with testosterone gel. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinemann, Lothar A, Moore, Claudia, Dinger, Juergen C, Stoehr, Diana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448206/
https://www.ncbi.nlm.nih.gov/pubmed/16573813
http://dx.doi.org/10.1186/1477-7525-4-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448206/
https://www.ncbi.nlm.nih.gov/pubmed/16573813
http://dx.doi.org/10.1186/1477-7525-4-23

Ejemplares similares